Extension of lymph node dissection in the surgical treatment of esophageal and gastroesophageal junction cancer: seven questions and answers

The role of two- or three-field nodal dissection in the surgical treatment of esophageal and gastroesophageal junction cancer in the minimally invasive era is still controversial. This review aims to clarify the extension of nodal dissection in esophageal and gastroesophageal junctional cancer. A ba...

Full description

Saved in:
Bibliographic Details
Published in:Future oncology (London, England) England), 2023-02, Vol.19 (4), p.327-339
Main Authors: Vagliasindi, Alessio, Franco, Filippo Di, Degiuli, Maurizio, Papis, Davide, Migliore, Marcello
Format: Article
Language:English
Subjects:
esophageal cancer
Esophageal Neoplasms - pathology
Esophagectomy
Esophagogastric Junction - pathology
Esophagogastric Junction - surgery
gastroesophageal junctional cancer
Humans
Ivor Lewis esophagectomy
Lymph Node Excision
Lymph Nodes - pathology
Lymph Nodes - surgery
lymphadenectomy
minimally invasive surgery
Neoplasm Staging
nodal dissection
robotic esophagectomy
Stomach Neoplasms - pathology
Stomach Neoplasms - surgery
three-field nodal dissection
two-field nodal dissection
VATS
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The role of two- or three-field nodal dissection in the surgical treatment of esophageal and gastroesophageal junction cancer in the minimally invasive era is still controversial. This review aims to clarify the extension of nodal dissection in esophageal and gastroesophageal junctional cancer. A basic evidence-based analysis was designed, and seven research questions were formulated and answered with a narrative review. Reports with little or no data, single cases, small series and review articles were not included. Three-field lymph node dissection improves staging accuracy, enhances locoregional disease control and might improve survival in the group of patients with cervical and upper mediastinal metastatic lymph nodal involvement from middle and proximal-third esophageal cancer.
ISSN:1479-6694
1744-8301
DOI:10.2217/fon-2021-0545